Grenoble Institute of Neuroscience, INSERM U836, Site Santé de la Tronche, Bâtiment Edmond J Safra, Chemin Fortuné Ferrini, BP170, 38042 Grenoble Cedex 9, France.
J Biol Chem. 2010 Oct 29;285(44):34168-80. doi: 10.1074/jbc.M110.104919. Epub 2010 Jul 7.
Maurocalcine has been the first demonstrated animal toxin acting as a cell-penetrating peptide. Although it possesses competitive advantages, its use as a cell-penetrating peptide (CPP) requires that analogues be developed that lack its characteristic pharmacological activity on ryanodine-sensitive calcium channels without affecting its cell-penetrating and vector efficiencies. Here, we present the synthesis, three-dimensional (1)H NMR structure, and activity of D-maurocalcine. We demonstrate that it possesses all of the desired features for an excellent CPP: preserved structure, lack of pharmacological action, conserved vector properties, and absence of cell toxicity. This is the first report of a folded/oxidized animal toxin in its D-diastereomer conformation for use as a CPP. The protease resistance of this new peptide analogue, combined with its efficient cell penetration at concentrations devoid of cell toxicity, suggests that D-maurocalcine should be an excellent vector for in vivo applications.
Maurocalcine 是首个被证实可作为穿透肽的动物毒素。尽管它具有竞争优势,但要将其用作穿透肽(CPP),就需要开发缺乏其对 Ryanodine 敏感钙通道的特征药理学活性而不影响其穿透细胞和载体效率的类似物。在这里,我们展示了 D-马罗钙素的合成、三维(1)H NMR 结构和活性。我们证明它具有作为优秀 CPP 的所有理想特征:保留结构、缺乏药理作用、保守的载体特性和无细胞毒性。这是第一个关于作为 CPP 使用的 D-对映异构体折叠/氧化动物毒素的报告。这种新的肽类似物的蛋白酶抗性,结合其在无细胞毒性浓度下的有效细胞穿透能力,表明 D-马罗钙素应该是体内应用的优秀载体。